ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting

Luo, Fan; Lin, Yuxin; Zhang, Xiaodong; Li, Yanqin; Su, Licong; Zhou, Shiyu; Xu, Ruqi; Gao, Qi; Chen, Ruixuan; Guo, Zhixin; Nie, Sheng*; Xu, Xin*南方医科大学
European Journal of Preventive Cardiology2024-2-15DOI: 10.1093/eurjpc/zwad354
10阅读
引用收藏
分享

摘要

Aims This study aimed to evaluate the safety of the currently recommended target of LDL cholesterol (LDL-C) control on mortality in patients with atherosclerotic cardiovascular disease (ASCVD).Methods and results Using deidentified electronic health record data, we conducted a multicentre retrospective cohort study involving individuals with documented ASCVD who had received statin treatment for at least 3 months across China. The primary outcomes assessed encompassed all-cause mortality, CV mortality, and non-CV mortality. Relationships between post-treatment LDL-C concentrations and outcomes were evaluated using restricted cubic spline curves based on Cox proportional hazards regression analyses. Additionally, competitive risk models were employed to explore associations between LDL-C levels and cause-specific mortality. Among 33 968 participants, we identified nearly linear associations of post-treatment LDL-C level with all-cause mortality and CV mortality during a median follow-up of 47 months. Notably, patients who achieved the recommended target of LDL-C (<1.4 mmol/L) were at significantly lower risks of all-cause mortality [hazard ratio (HR), 0.77; 95% confidence interval (CI), 0.69-0.86] and CV mortality (subdistribution HR, 0.68; 95% CI, 0.58-0.79), compared with those with LDL-C >= 3.4 mmol/L. This survival benefit was consistent in patients with different intensities of LDL-C reduction and other subgroup analyses. And no correlation was found between post-treatment LDL-C concentration and non-CV mortality.Conclusion Our findings supported the safety of currently recommended target of LDL-C control and the 'lower is better' principle in patients with ASCVD.Lay summary Intensive control of LDL cholesterol (LDL-C) has been widely recommended for cardiovascular (CV) protection in patients with atherosclerotic CV disease. Nevertheless, a U-shaped association between LDL-C levels and all-cause mortality has been noted in several general population studies, prompting concerns regarding the safety of intensive lipid control. In this multicentre cohort comprising 33 968 patients at the highest CV risk, we found that patients with lower post-treatment LDL-C level were at lower risk of both all-cause and CV mortality, and this survival benefit was unaffected by intensity of LDL-C reduction, types of lipid-lowering agents, and other clinical characteristics.

学科与关键词

关键词
Secondary preventionLDL-CAll-cause mortalityCardiovascular mortality
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Journal of Preventive Cardiology
发表日期
2024-02-15
卷期
第 31 卷, 第 3 期
页码
337-345
DOI
10.1093/eurjpc/zwad354
语言
ENGLISH
成果收录
SCIE
资助标注
The authors thank all medical centres and patients for their participation in the Chinese Renal disease Data System (CRDS).

作者

  • L

    Luo, Fan (第一作者)

    southern med univ

  • L

    Lin, Yuxin

    southern med univ

查看全部 12 位作者收起作者
  • Z

    Zhang, Xiaodong

    southern med univ

  • L

    Li, Yanqin

    southern med univ

  • S

    Su, Licong

    southern med univ

  • Z

    Zhou, Shiyu

    southern med univ

  • X

    Xu, Ruqi

    southern med univ

  • G

    Gao, Qi

    southern med univ

  • C

    Chen, Ruixuan

    southern med univ

  • G

    Guo, Zhixin

    southern med univ

  • N

    Nie, Sheng (通讯)

    southern med univ

  • X

    Xu, Xin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417